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Abstract. Steroid hormones regulate a wide range of processes in our body, and their effects are
mediated by steroid receptors. In addition to their physiological role, these receptors mediate the
effects of endocrine disrupting chemicals (EDCs) and are widely used targets for dugs involved
in the treatment of numerous diseases, ranging from cancer to inflammatory disorders. Over the
last fifteen years, the zebrafish has increasingly been used as an animal model in steroid receptor
research. Orthologues of all human steroid receptor genes appear to be present in zebrafish.
All zebrafish steroid receptors have been characterized in detail, and their expression patterns
have been analyzed. Functional studies have been performed using morpholino knockdown
of receptor expression and zebrafish lines carrying mutations in one of their steroid receptor
genes. To investigate the activity of the receptors in vivo, specific zebrafish reporter lines have
been developed, and transcriptomic studies have been carried out to identify biomarkers for
steroid receptor action. In this review, an overview of research on steroid receptors in zebrafish
is presented, and it is concluded that further exploitation of the possibilities of the zebrafish
model system will contribute significantly to the advancement of steroid receptor research in
the next decade.
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1. Steroids and Steroid Receptors
Steroid hormones are signalingmolecules that regulate awide variety of physiological processes
in our body. Two main classes of steroid hormones exist: sex steroids and corticosteroids. The
secretion of sex steroids is controlled by the hypothalamus-pituitary-gonadal axis, and these
hormones are primarily produced in the ovary in females and in the testis in males. Sex steroids
regulate sexual differentiation and reproduction, and they can be subdivided into three groups:
estrogens, progestogens and androgens. The hypothalamus-pituitary-adrenal axis regulates the
secretion of corticosteroids, which are synthesized in the cortex of the adrenal gland. They can
be subdivided into two groups: mineralocorticoids, which regulate our salt and water balance,
and glucocorticoids, which are involved in the stress response and regulate processes like glu-
cose metabolism and immune function.
All steroid hormones are synthesized from the common precursor molecule cholesterol. The
rate-limiting step in this process is the transport of cholesterol across the mitochondrial mem-
branes, which is controlled by steroidogenic acute regulatory protein (StAR). Next, choles-
terol is converted to pregnenolone, which is subsequently converted to progesterone, the main
endogenous progestogen in our body. From progesterone, the mineralocorticoid aldosterone is
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synthesized in a two-step-process. Pregnenolone can also be converted to 17-OH-progesterone,
which serves as a precursor for the biosynthesis of cortisol, our main glucocorticoid hormone.
A third steroid biosynthesis pathway generates androgens and estrogens and starts with the
production of androstenedione (A2) from pregnenolone. A2 can be converted into the androgens
testosterone (T) and dihydrotestosterone (DHT). Finally, T serves as a substrate for the enzyme
aromatase which produces estradiol (E2), our main endogenous estrogen.
Upon secretion by the endocrine organs, steroid hormones reach their target cells through
the blood. Inside cells, steroid hormones bind and activate steroid receptors. For each of the
five subclasses of steroid hormones a specific receptor type exists that mediates their effects:
the Estrogen Receptors 𝛼 and 𝛽 (ER𝛼 and ER𝛽), the Progesterone Receptor (PR), Androgen
Receptor (AR), Glucocorticoid Receptor (GR), and Mineralocorticoid Receptor (MR). These
receptors belong to the superfamily of nuclear receptors. Evolutionary analysis has revealed that
the members of this receptor family have evolved from one ancestral steroid receptor that was
sensitive to estrogens, through a series of gene duplication and diversification events [1]. They
show a high level of similarity and share a common modular domain structure. They all contain
an N-terminal domain that is variable in length, a small well-conserved DNA-binding domain
(DBD), and a larger, moderately conserved, C-terminal ligand-binding domain (LBD).
Steroid receptors are located intracellularly, and in the absence of hormone they form a
multiprotein complex with heat shock proteins and immunophilins, which keep them in an
inactive state with high affinity for their cognate ligands. Upon ligand binding, the receptors
dissociate from the repressor protein complex and a conformational change is induced. In the
active conformation, the receptors act as transcription factors. They are able to bind to specific
target sites in the DNA, called hormone response elements (HREs), and upon recruitment of
different types of transcriptional coregulator proteins the transcriptional rate of a nearby gene
is altered. Additionally, steroid receptors are able to alter gene transcription by interacting with
other transcription factors and alter the activity of these proteins. Besides these ‘genomic’
actions of steroid receptors, rapid ‘nongenomic’ mechanisms of steroid receptor action have
been demonstrated, but the intracellular signaling pathways underlying these effects have not
been unraveled in full detail yet. Finally, the G protein-coupled estrogen receptor (GPER, pre-
viously termed GPR30) has been shown to mediate rapid effects of estradiol and aldosterone
[2], and progesterone is known to activate membrane Progestin Receptors (mPRs), which are
members of the Progestin and AdipoQ Receptor family [3]. These latter two receptor types are
beyond the scope of this review, which will focus on the classical steroid receptors from the
nuclear receptor superfamily.
2. Steroid Receptor Research in Zebrafish
In this review, an overview is presented of research on steroid receptors using the zebrafish
(Danio rerio) as a model system. The zebrafish was originally used as an animal model for
studies on embryonic development and morphogenesis, and it is still widely used in research
on vertebrate development [4, 5]. However, over the last decade the zebrafish has also emerged
as an important model system for eco-toxicological [6] and biomedical research [7, 8]. Several
characteristics make it a highly versatile researchmodel. Their easymaintenance, high fecundity
and the small size and optical transparency of the embryos and larvae make them highly suitable
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for large-scale studies. Since most compounds can easily penetrate the skin of these organisms,
drug and toxicological screenings can be performed by simply adding the compounds to the
water. The completion of the genomic sequence of the zebrafish greatly facilitated forward and
reverse genetic studies in zebrafish. The generation of mutant and transgenic fish lines opened
up new possibilities, and novel genome-editing techniques, like the CRISPR/Cas9 technology,
will further advance the field.
A large amount of the research that has been performed on steroid receptors in zebrafish
has been aimed at studying the effects of endocrine disrupting chemicals (EDCs). EDCs are
natural or synthetic compounds that occur in the environment and disrupt the function, levels
and distribution of endogenous hormones of exposed organisms, by mimicking or antagoniz-
ing the actions of hormones, or by modulating hormone synthesis and metabolism [9]. This
may ultimately lead to altered development and/or reproduction in humans and wildlife. EDCs
form a heterogeneous group of substances, encompassing natural and synthetic hormones and
seemingly unrelated compounds like pesticides, polychlorinated biphenyls (PCBs), Bisphenol A
(BPA), phthalates, flavonoids and polycyclic musks [10, 11]. The main mechanism of action for
these compounds is generally suggested to be agonistic or antagonistic interaction with steroid
receptors. Zebrafish are commonly used for monitoring EDC activity. Phenotypic endpoints like
growth, sexual differentiation, sex ratio, egg production and fertilization success are commonly
used for monitoring EDC activity, and these biomarkers are used in partial and full life cycle
studies [12, 13]. A lot of studies on zebrafish steroid receptor action have aimed to identify
novel molecular biomarkers or screening approaches for EDC activity which could replace or
complement the phenotypic endpoints. In addition, many investigations were focused on unrav-
eling the mechanism of action of EDCs, especially using approaches for genetic knockdown of
steroid receptor function.
Research on steroid receptors in zebrafish started in 2002 with the characterization of the
zebrafish ERs, and almost ten years later all zebrafish steroid receptors had been identified and
characterized (for an overview see Table 1). All mammalian steroid receptor genes appeared
to have one orthologue in zebrafish, apart from the gene encoding Er𝛽, of which two copies
were found in the zebrafish genome. As a first step in the characterization, the zebrafish recep-
tors were used in reporter assays in cultured (mostly mammalian) cells. In general, the ligand
specificity did not differ much from the mammalian receptors. Second, expression analysis
was performed, mostly by in situ hybridization, since the availability of antibodies specific for
(zebra)fish receptors is limited. After these initial steps, functional in-vivo studies have been
performed. Knockdown of the receptor using morpholinos, which are antisense oligonucleotide
analogs often used in zebrafish research, has revealed the function of the receptor during embry-
onic and larval stages. In recent years, it has become clear that some of the phenotypes caused by
this approach may result from unintended nonspecifc morpholino actions [14]. This issue may
be overcome by comparing the results frommorpholino studies to data obtained using zebrafish
lines with mutations in steroid receptor genes, and this has provided further insight into the in
vivo action of several steroid receptors. For Er and Gr, luciferase and Green Fluorescent Protein
(GFP) reporter lines have been generated which allow in-vivo monitoring of the activity of these
receptors. Many functional studies have used transcriptomic analysis, initially using microarray
and more recently using RNA sequencing, to elucidate molecular pathways regulated by steroid
receptor action and to identify biomarkers for steroid receptor activity. In the following sections,
doi:10.11131/2017/101286 Page 3
Nuclear Receptor Research
Table 1: Overview of steroid receptor family in zebrafish (Danio rerio).
Receptor Gene name and aliases ENSEMBL Gene ID1 GenBank mRNA Ref. Seq. no.2 Reference
Er𝛼 nr3a1, er𝛼, era, esr1 ENSDARG00000004111 NM_152959.1 [15–17]
Er𝛽1 nr3a2-a, er𝛽1, erb1, esr2b ENSDARG00000034181 NM_174862.3 [15–17]
Er𝛽2 nr3a2-b, er𝛽2, erb2, esr2a ENSDARG00000016454 NM_180966.2 [15–17]
Pr nr3c3, pr, pgr ENSDARG00000035966 NM_001166335.1 [39, 40]
Ar nr3c4, ar ENSDARG00000067976 NM_001083123.1 [48–50]
Gr nr3c1, gr, utouto ENSDARG00000025032 NM_001020711.3 [57]
Mr nr3c2, mr ENSDARG00000102082 NM_001100403.1 [85]
1http://www.ensembl.org/Danio_rerio/Info/Index
2https://www.ncbi.nlm.nih.gov/genbank/
for each of the five steroid receptor types the zebrafish research performed over the last fifteen
years will be discussed.
3. The Zebrafish Ers
Fifteen years ago, several groups reported on the identification of three different Er encoding
genes in zebrafish [15–17]. Phylogenetic analysis showed that one cDNA originated from the
zebrafish orthologue of the mammalian ER𝛼gene, and that the other two cDNAs were products
from two ER𝛽orthologues. It was concluded that the identified er𝛽 cDNAs originated from
duplicated er𝛽 genes in the zebrafish genomes. These duplicate er𝛽 genes had been shown
previously in other fish species like goldfish [18] and atlantic croaker [19]. Er𝛽2 had a slightly
higher affinity for E2 than the other two zebrafish Ers, which was reflected in a higher potency
in in-vitro reporter assays, in which a luciferase gene was driven by a promoter containing an
estrogen response element (ERE) [15, 20]. E2, the metabolites estrone (E1) and estriol (E3), and
the synthetic estrogen diethylstilbestrol (DES) showed similar agonistic activity on all three
receptors [15, 16], whereas the synthetic ligands ICI 164384 (ICI) and 4-hydroxytamoxifen
(OHT) acted as antagonists on all zebrafish Ers.
Expression analysis of the three genes encoding Ers showed that during zebrafish devel-
opment, three phases can be distinguished [16, 20, 21]. During the first phase, the presence
of maternal transcripts for Er𝛽1 [20–22] and Er𝛽2 [16] has been demonstrated by RT-PCR
and RNAse protection assay respectively. Between the mid-blastula stage and 72 hours post
fertilization (hpf), the expression levels of all three er genes is decreased, although by in-situ
hybridization it was shown that some cell types show high levels of specific er mRNAs. For
example, epidermal cells were demonstrated to contain high er𝛽2 mRNA levels at this stage
[21]. After 72 hpf, all er genes start to be expressed at high levels [16, 20–22], and particularly
high levels of er𝛽1 and er𝛽2 expression were found during the second week of development in
neuromasts of the lateral line, a mechanoreceptive system specific to aquatic vertebrates [21].
In adult fish, expression of all three receptor subtypes was demonstrated by RT-PCR in tissues
involved in reproduction like brain, pituitary, ovary and testis, but also in nonreproductive
tissues like liver, intestine and eyes [15, 22, 23]. In-situ hybridization on brains of adult females
showed distinct but partially overlapping patterns of expression in two neuroendocrine regions,
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the preoptic area and the mediobasal hypothalamus [15]. Hepatic expression of er𝛼 mRNA in
adult fish was upregulated upon E2 treatment, and this effect appeared to be mediated by Er𝛼
and Er𝛽2, but not Er𝛽1 [23, 24].
Knockdown of the expression of the zebrafish er genes has been performed in several studies.
Temporary knockdown of the er𝛽2 expression using a morpholino resulted in the disrupted
development of the neuromasts (absence of hair cells) in themorpholino-treated embryos, which
was attributed to an aberrant activation of the Notch signaling pathway [25]. Induction of spe-
cific target genes of Er𝛽2 and Er𝛼 could also be inhibited by morpholino knockdown of the
receptor [26]. Knockdown of er𝛼 expression during embryonic stages by morpholino-induced
blocking of translation of maternal mRNA resulted in severe developmental defects and early
mortality [27]. Using a combination of chemical mutagenesis and high-throughput sequencing
[28], a mutant zebrafish line was generated, which carried a mutation in the gene encoding Er𝛽2
(resulting in an 8 amino acid insertion in the ligand-binding domain [29]). Unfortunately, the
readouts used in studies on this mutant line were different from those used in the morpholino
studies, so validation of the morpholino data was not possible. This mutant line displayed
increased testosterone and 17𝛽-estradiol (E2) levels and, probably as a result of the hormonal
imbalance, distorted sexual ratios and altered testicular morphology. It was concluded that Er𝛽2
plays an important role in the feedback regulation of steroid biosynthesis, in line with its elevated
expression in the gonads and neuroendocrine regions of the brain. In addition, a decreased
immune response to a viral infection was found in this mutant fish [29].
Several transgenic reporter fish lines are available to study the activity of Er in vivo. In
these lines, an Er-responsive promoter is genetically fused to a reporter gene encoding either
luciferase or GFP. Using a transgenic line with the luciferase gene coupled to a promoter with a
single estrogen response element (ERE), Er activity could be measured after 96 hour exposure
to estrogens by measuring the luciferase activity in tissue homogenates [17, 30]. This assay
has been performed using adult zebrafish and juveniles, in which adults appear to be more
responsive. In addition, two transgenic zebrafish lines have been generated in which GFP is
used, which makes it possible to locate the reporter activity using fluorescence microscopy.
In the first line, a promoter with 5 EREs was utilized, and GFP expression was observed in
embryonic and larval zebrafish in the brain, liver and pancreas after estrogen exposure [31, 32].
Estrogen treatment of larvae also induced expression of GFP in cells in the ventral fin adjacent to
the cloaca, in the developing olfactory organ, and in the heart. This induction could be inhibited
by the ER antagonist ICI182,780 (fulvestrant). Interestingly, GFP induction by estrogens like
EE2 and genistein showed marked differences in the tissue specificity of the response [31].
In adult fish, males showed no GFP expression in the liver, whereas females displayed dim
expression in this tissue, which could be increased upon estrogen exposure. Ovaries and (male
and female) pituitaries were GFP-positive without exposure to exogenous estrogens, so this was
considered to reflect Er activation by endogenous estradiol. In another transgenic line GFP was
coupled to the promoter of the brain aromatase b gene (cyp19a1b), resulting in specific GFP
expression in radial glial cells in the area bordering the brain ventricles [33]. Before 9 days post
fertilization (dpf), the GFP expression was only observed after induction by estrogens [34].
Various transcriptomic analyses have been carried out in order to identify novel molecular
biomarkers for Er activity [35]. The liver and telencephalon transcriptome have been determined
using microarray analysis of adult male and female fish after exposure to EE2 [36, 37]. Whole
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body transcriptome analysis was performed on male adult fish after exposure to E2 in another
microarray study [38]. Microarray analysis has also been performed during early developmental
stages (1, 2, 3 and 4 dpf). In addition to well-known Er target genes like vtg1 (the only gene
induced by estrogens at all stages studied [32]), vtg3, vtg4 and er𝛼, these studies also revealed
Er regulation of many metabolic genes [36, 37] and genes involved in cell cycle and DNA repair
[38].
4. The Zebrafish Pr
Just like in most other teleost fish species, a single pr gene was found in zebrafish [39, 40],
although duplicate pr genes (pr1 and pr2) have been demonstrated in the European eel [41].
The two pr genes in the eel, like many other duplicated genes, result from a whole genome
duplication that happened at the base of teleost evolution around 320–350 million years ago
[42]. The orthologue of the eel pr2 gene was most likely lost early during teleost evolution,
soon after the order of Anguilliformes (to which the eels belongs) had branched off the main
teleost lineage. The zebrafish Pr binds with high affinity (k𝑑 in the nanomolar range) to the
main endogenous progestogen in zebrafish, 17𝛼,20𝛽-dihydroxy-4-pregnen-3-one (DHP)[39].
DHP is converted from 17-OH-progesterone by 20𝛽-hydroxysteroid dehydrogenase (Hsd20b),
an enzyme that has only been identified in teleosts [43, 44]. The zebrafish Pr activated the
mousemammary tumor virus (MMTV) promoter in luciferase assays upon binding to DHP, pro-
gesterone, 17-OH-progesterone, 17𝛼,20𝛽,21-trihydroxy-4-pregnen-3-one (20𝛽-S, another fish-
specific endogenous progestogen), and the synthetic progestin promegestone (R5020) [39, 40].
In testicular explants, the release of 11-KT was induced by DHP and this response could be
inhibited by the antagonist RU486 [40].
Pr expression analysis using RT-PCR showed no maternally deposited transcripts, and the
first detectable mRNA levels were found at 8 hpf [40]. In adults, the pr transcript and protein
were detected by RT-PCR and western blot and appeared to be abundant in the ovaries, testis,
and brain and scarce or undetectable in the liver, intestine, muscle, heart and gills [39, 40]. In
the ovary, high mRNA and protein levels were found in follicular cells and early stage oocytes
(stages I and II), with very low levels within maturationally competent late-stage oocytes (IV),
which is in line with the nondetectable levels in early-stage fertilized embryos [39, 45]. Sim-
ilarly, in the testis, mRNA and protein expression was observed in spermatogonia and early
spermatocytes and not in spermatids or sperm [39]. In the brain, immunohistochemical analysis
showed robust Pr levels in the two main neuroendocrine regions of the brain: the preoptic
area and the mediobasal hypothalamus [39]. These expression data indicate that Pr regulates
reproductive signaling in the brain, early germ cell proliferation in testis and ovarian follicular
functions, but not final oocyte or sperm maturation.
Using transcription activator-like effector nucleases (TALENs), several pr mutant fish lines
have been made [46, 47]. Three lines were generated with small deletions in exon 1 of the gene
encoding Pr, resulting in frameshifts in the gene starting at the sequence encoding amino acid
51, 47 and 205 [46]. Another prmutant line was made by deletion of a large part (13.4 kb) of the
pr gene between exon 1 and 6, resulting in a frame shift from the codon encoding amino acid
151 [45]. Thesemutants showed highly similar phenotypes. Homozygous females were infertile,
whereasmales were fertile [45, 46]. In themutant females, oocytes appeared tomature normally,
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but these mature oocytes were trapped within the follicular cells and failed to ovulate from the
ovaries, even after induction by human Chorionic Gonadotropin (hCG) [45, 46]. Apparently,
Pr activity is required for ovulation, and it was shown that the Prostaglandin E Receptor 4 was
involved, since the expression of this receptor is induced upon Pr activation and antagonists of
this receptor inhibited hCG-induced ovulation [45]. Transcriptomic analysis of follicular cells
from pr mutant fish using RNA sequencing revealed gene networks involved in the induction
of ovulation, that are well conserved between zebrafish, mice and humans, and in which genes
are enriched that are involved in inflammation, apoptosis, vascularization, cell-matrix adhesion,
extracellular matrix remodeling, and the cell cycle [47].
5. The Zebrafish Ar
The cloning and characterization of the zebrafish ar gene was reported by several groups
[48–50]. Although in several other fish species the occurrence of duplicate ar genes had been
reported, only one ar gene was identified in the zebrafish genome. A single copy of the ar gene
is present in Cypriniformes (e.g. common carp, goldfish, zebrafish), Characiformes (e.g. black
widow tetras) and Siluriformes (e.g. sharptooth catfish), so the duplicate copy must have been
lost during the early evolution of the Otophysi lineage, which gave rise to these orders of fish
species [51]. The zebrafish ar gene appears to be the orthologue of the gene that encodes the
Ar-A isoform in fish species containing two ar genes.
The zebrafish Ar was demonstrated to bind the endogenous steroids T, DHT,
11-ketotestosterone (11-KT) with high affinity (k𝑑 in nanomolar range), A2 with an approx-
imately ten-fold lower affinity and the synthetic steroids 17𝛼-methyltestosterone (MT) and
17𝛼-dimethyl-19-nortestosterone (mibolerone, MB) with a slightly higher affinity [48, 50].
Transcriptional activation of an MMTV promoter driving a luciferase gene in human and
zebrafish cells was found to be similar for T, 11-KT, MT, and DHT (although for DHT the
potency was lower in zebrafish cells than in human cells) [49, 50]. Flutamide was shown to
act as an antagonist of the zebrafish Ar in these reporter assays [50]. Additionally, It was
demonstrated that the main endogenous Ar ligand in zebrafish is 11-KT, which is produced
from androstenedione in a two-step process [50]. The biosynthesis of the main mammalian
androgens, T and DHT, is limited in zebrafish [50, 52], just like in other fish species [44].
Expression levels of the ar gene during development were determined using RT-PCR.Mater-
nal armRNAwas detected and the concentration of ar transcripts decreased until around 12 hpf,
after which it shows a gradual increase until at least 14 dpf [49]. Using in-situ hybridization,
ar transcripts were found in the presumptive pronephros and in olfactory placodes in 24 hpf
embryos and at 3–5 dpf in the pineal organ anlage and the retina [53]. In adult fish, armRNAwas
detected in the gonads, brain, kidney, liver, skin, muscle and eye tissue by RT-PCR [49]. By in-
situ hybridization the presence of armRNAwas demonstrated in the testis, in the subpopulation
of Sertoli cells contacting early spermatogonia (DeWaal 2008) and in brain regions known to be
involved in neuroendocrine regulation, like the preoptic area, the periventricular hypothalamus
and discrete telencephalic regions [53].
Microarray analysis of the transcriptome of livers from adult female zebrafish exposed to
the androgen 17𝛼-methyldihydrotestosterone (MDHT) revealed regulation of genes involved
in steroid and retinoic acid metabolism, hormone transport and regulation of cell growth and
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proliferation [54]. In another study, the effect of exposure of adult fish to the AR antagonists
flutamide and vinclozolin on the gonadal transcriptome in males and females was determined
using microarray analysis [55]. Multiple pathways were shown to be regulated, which were
involved in steroidogenesis, spermatogenesis and fertilization. These pathways included the
integrin, actin, steroidogenic factor-1, Fgf receptor signaling pathway and the polyamine and
androgen synthesis pathway [55]. The transcriptional effect of 11-KT exposure of zebrafish
larvae between 5 and 6 dpf was investigated by whole body microarray analysis [56]. Four
regulated genes involved in hormone metabolism were additionally studied in detail: cyp2k22,
slco1f4, lipca, sult2st3, and it was demonstrated using the antagonist nilutamide that these genes
are specific targets of Ar [56].
6. The Zebrafish Gr
Soon after the Ar, the zebrafish Gr was characterized [57]. Only a single gr gene was identified
in the zebrafish genome, although many fish species were known to have two gr orthologues.
Just like the other duplicate steroid receptor gene copies, the two gr orthologues were a result
of the whole genome duplication that had occurred early in the teleost lineage, and they are
called gr1 and gr2 [58]. Phylogenetic and syntenic analysis showed that the zebrafish genome
contains an orthologue of the gr2 gene, and that an ancestor of the zebrafish has lost its gr1
gene due to a genomic rearrangement in chromosome 21 [57]. This loss must have been a
relatively recent event, since the common carp, which belongs to the same family (Cyprinidae)
as the zebrafish, has both gr1 and gr2 orthologue genes [58]. Luciferase assays showed that the
zebrafishGr is able to activate theMMTVpromoter upon binding to the synthetic glucocorticoid
dexamethasone (EC50 in the subnanomolar range) and the endogenous hormone cortisol (with
a ∼30-fold lower potency)[57]. However, dexamethasone and cortisol were inactive in a larval
regeneration-inhibition assay in which other glucocorticoids like beclomethasone dipropionate
were shown to be active in a Gr-dependent manner [59, 60]. This activity appeared to correlate
with the ability to induce the expression of the cripto-1 gene. It was demonstrated that specific
ligand-induced Gr conformational changes induce these effects, with a particular role for the
functional groups at the C17 position of the cortisol backbone [60].
Remarkably, an alternative splice variant of Gr was identified in zebrafish, which shows a
high level of similarity with the human GR 𝛽-isoform [57]. In humans, this C-terminal splice
variant is not able to bind ligand and has been shown to act as a dominant-negative inhibitor
of the canonical GR (called GR𝛼), although this function is debated [61, 62]. The zebrafish
Gr𝛽 diverges from Gr𝛼 at the same point as its human equivalent, and it showed dominant-
negative activity in luciferase reporter assays [57, 63]. The zebrafishGr𝛽 hasmost likely evolved
independently from the human GR𝛽, since the amino acid sequence of its isoform-specific C-
terminus shows no homology with the human sequence, and the exon encoding this Gr𝛽-specific
sequence is located at a different position in the gr gene [57]. Further analysis of the role of Gr𝛽
revealed no dominant-negative activity in vivo, and the function of this splice variant remains
unclear [63, 64].
The expression levels of gr during zebrafish development were measured by RT-PCR and
the results showed the presence of maternal transcripts at fertilization and a decrease in mRNA
levels until 24 hpf [65]. After this time point, gr mRNA levels are increased again at 48 hpf
doi:10.11131/2017/101286 Page 8
Nuclear Receptor Research
and remain stable until at least 7dpf [65]. In-situ hybridization showed no spatial restriction for
gr mRNA during embryonic stages, but high expression levels in the brain, liver and intestinal
bulb at 5 dpf [57, 66–68]. This embryonic expression pattern was confirmed using immunohis-
tochemistry [68]. In adults, expression was demonstrated in spleen, liver, intestine, heart, brain,
gill and muscle tissue by RT-PCR [57].
The expression of the zebrafish gr gene has been knocked down using two types of mor-
pholinos: splice-blocking morpholinos that hybridize to a splice site and interfere with splicing
at their target site in the genome and translation-blocking morpholinos, which interfere with
translation of a transcript by hybridizing to the translation start site. Interestingly, injection
of the first type of morpholinos into early zebrafish embryos did not elicit any visible mal-
formations [59, 64, 67], whereas the latter type resulted in severe developmental defects, like
craniofacial and caudal malformations, delayed somitogenesis, and defects in somite and tail
morphogenesis [67, 68]. These effects were shown to be specific for the gr knockdown, since
gr mRNA rescued the phenotypes of the morpholino-treated embryos [67, 68]. In addition,
morpholino-treated embryos had smaller hearts and reduced cardiac function [69]. The strong
effect of the translation-blocking morpholino was explained by its ability to target maternally
deposited mRNA, whereas a splice-blocking morpholino only interferes with mRNA which is
transcribed de novo, so it is only effective after zygotic transcription has started [67]. Microarray
analysis of embryos at 5 and 10 hpf demonstrated that the early gr expression has an important
role in cell survival and inhibits apoptosis [67]. At 24 and 36 hpf, a microarray analysis showed
disturbed regulation of genes involved in numerous developmental processes in embryos treated
with a translation-blocking morpholino [70].
Interestingly, transcriptomic analysis revealed that knockdown of gr expression by a mor-
pholino regulates a different cluster of genes than activation of the receptor by a 6 h treatment
with a high dose (100 𝜇M) of the synthetic glucocorticoid dexamethasone [64]. These data
suggest that Gr regulates two clusters of genes in zebrafish embryos: one that is regulated under
basal conditions and one that is regulated upon increased receptor activation, after stress or upon
treatment with a pharmacological dose of a glucocorticoid. The first cluster mainly contains
genes involved in cell cycle and cell death, whereas the latter cluster mainly contains genes
involved in catabolic processes like proteolysis and glycogen breakdown [64]. In support of
this hypothesis, in another microarray study treatment with a low dose of dexamethasone (50
nM) between 0 and 5 dpf was found to mainly regulate genes involved in cell cycle and cell
death [71].
Finally, ion regulation was severely compromised in embryos upon morpholino knockdown
of gr expression. Ca2+ uptake was impaired [72], as well as Na+ uptake following 24 h
exposure to acidic water [73]. These results are in line with a decreased number of ionocytes in
morpholino-treated embryos, in particular Na+-K+-ATPase rich cells (NaRCs) and H+-ATPase
rich cells (HRCs) [74]. Furthermore, the secretion of acid was decreased, which could be
explained by a suppressed expression of transporters involved in acid secretion [72].
In a forward-genetic screen of chemically mutated zebrafish a mutation was identified in
the gr gene, which results in a single amino acid substitution in the DBD of the receptor,
making the Gr transcriptionally inactive [75]. In humans, a mutation in the equivalent amino
acid occurs naturally and also results in a transcriptionally inactive receptor and results in resis-
tance to glucocorticoids [76]. This mutant zebrafish shows no morphological malformations, is
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adult-viable and displays increased cortisol levels due to a lack of feedback on the regulation
of its secretion. Behavioral studies of adult fish revealed a depression-like profile, including
decreased exploratory behavior and impaired habituation to repeated exposure to an anxiogenic
environment [75]. Administration of the antidepressant fluoxetine as well as social interactions
were shown to restore normal behavior [75, 77]. Using this mutant, it was demonstrated that
Gr mediates the glucocorticoid-induced inhibition of leukocyte migration upon wounding [78]
and the stimulation of the formation of hematopoietic stem and progenitor cells (HSPCs) by
glucocorticoids [79]. In addition, it was found that light adaptation in the retina was disturbed
in mutant larvae [80]. The relatively mild phenotype of this mutant zebrafish line has cast
doubt on the specificity of some of themorphological malformations observed uponmorpholino
knockdown. This is supported by very recent data from a Crispr/Cas9 gr knockout line, which
displays a similarly mild phenotype [81].
Gr activity could be measured using a transgenic line with a luciferase gene driven promoter
with four glucocorticoid response elements (GREs). By measuring in-vivo luciferase activity
in 5 dpf larvae of this line, the glucocorticoid activity of exogenous compounds could be deter-
mined, as well as the action of increased cortisol levels upon exposure to osmotic stress or
the administration of the precursor hormone pregnenolone [82]. In two other lines GFP was
coupled to a promoter containing six GREs [83] or nine GREs [84]. Ubiquitous fluorescence
was detectable from 14 hpf, and at 3 dpf the signal was more specifically expressed in GR target
tissues like the brain, liver and pronephros [84]. Due to the high sensitivity Gr activity was
also detected in compartments such as fin, eyes, and otic vesicles. In 5 dpf larvae, compounds
were screened for glucocorticoid activity, and the specificity of the response was confirmed
using morpholino or TALEN knockdown of the receptor or the antagonist RU486 [83, 84]. The
endogenous cortisol activity was monitored after osmotic stress and during the diurnal cycle
[83, 84]. In adult fish, fluorescence was observed in many tissues, such as the esophageal sacs
mucosa, ventricular epicardium, liver, intestinal mucosa, testis and ovary [84].
7. The ZebrafishMr
Finally, in 2011 the zebrafish mr gene was identified, which was shown to be present as a single
copy [85]. Using luciferase assays, this receptor was shown to activate the MMTV promoter
after binding of aldosterone, cortisol, and 11-deoxycorticosterone (DOC). Fish do not produce
aldosterone, but it has been suggested that in fish DOC has a similar function to aldosterone in
mammals [86]. DOC is putatively converted from progesterone by steroid 21-monooxygenase
(cyp21a1), but the presence of this enzyme has not been demonstrated in zebrafish and has
been poorly characterized in several other fish species [43, 44]. Interestingly, the human MR
antagonist spironolactone showed agonistic activity on the zebrafish Mr, whereas eplerenone
and nimodipine acted as antagonists of the zebrafish Mr [85]. A two-hybrid assay showed that
aldosterone, cortisol and DOC induced an interaction between the N- and C-terminal ends of the
zebrafishMr, whereas in the humanMR this interaction was exclusively induced by aldosterone
[85]. Surprisingly, spironolactone did not induce this N/C-interaction, and since this ligand had
agonistic activity, the functional significance of the N/C-interaction remains unclear [85].
Little is known about the expression pattern ofmr in zebrafish. Expression ofmr mRNAwas
shown by RT-PCR to be minimal immediately after fertilization and increased 52-fold between
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1.5 and 97 hpf, after which it remained stable until 146 hpf. Still, at this time point themrmRNA
level was significantly lower than the gr mRNA concentration [65]. Morpholino knockdown of
mr expression was performed in several studies on ion regulation, but no Mr effects on this
process were observed [72, 74, 87].
8. Future Perspective
An important aspect of steroid receptor research in zebrafish is the relatively limited number
of studies that have been performed in this area. A PubMed (https://www.ncbi.nlm.nih.
gov/pubmedsearch) search, using ‘zebrafish’ and the name of the steroid receptors (in as many
variations as possible) as search terms, returned a total of 308 published articles, of which more
than half involve research on Er (308). For comparison, the same searches with the search term
‘mouse’ instead of ‘zebrafish’ retrieved about 50 times more published papers (15,086). This
difference is not specific for research on steroid receptors in these animal models and rather
reflects the difference in popularity of the models in general, because the terms ‘mouse’ alone
also returned about 50 times more articles than the term ‘zebrafish’. Limiting the searches to
articles published in 2016 and 2017 showed a 20-fold difference, illustrating an increase in the
role of the zebrafish model in steroid receptor research.
In order to further increase the role of the zebrafish model system in steroid receptor research,
the advantages of this model system should be better exploited. Morpholino knockdown of the
receptor has been performed for all steroid receptor types, but the usage of morpholinos is cur-
rently under debate [14]. Fortunately, this technology is rapidly becoming obsolete. Within the
Zebrafish Mutation Project (http://www.sanger.ac.uk/resources/zebrafish/zmp/),
using a combination of chemical mutagenesis and high-throughput sequencing [28], mutant
zebrafish lines have been generated for all steroid receptor types. In addition, targeted muta-
genesis has become possible with the CRISPR/Cas9 technology [88], which also allows for
the generation of tissue-specific [89] and inducible gene knockout strategies [90]. Another
challenge that remains is the analysis of steroid receptor expression at the protein level, due to
the limited availability of antibodies specific for (zebra)fish receptors.
Approximately half of the zebrafish steroid receptor research involves ecotoxicological stud-
ies on EDCs. The zebrafish will become an increasingly popular model for screening for EDCs
due to the identification of novel (molecular) biomarkers and the generation of reporter lines for
the activity of steroid receptors (currently, only reporter lines for Er and Gr activity are avail-
able). In addition, the increased availability of specific receptor mutants will enhance studies on
the mechanism of action of EDCs in the zebrafish model. Furthermore, an increasing role for the
zebrafish in biomedical research involving steroid receptors can be expected. Current research
aiming at the discovery of novel steroid drugs focuses on the identification of selective receptor
modulators, which are steroids that induce desired pharmacological effects without eliciting
adverse effects. The zebrafish is highly suitable for in-vivo phenotypic screening and can be
used to study compounds that dissociate desired from adverse effects. Targeted mutagenesis of
receptor domains involved in e.g. DNA binding, dimerization or interaction with transcriptional
coregulators will further advance our understanding of the specific molecular actions of steroid
drugs, and how they translate into their desired and adverse pharmacological effects. In these
ecotoxicological and biomedical studies the evolutionary distance of the zebrafish from humans
doi:10.11131/2017/101286 Page 11
Nuclear Receptor Research
compared to mammalian model organisms like mice and rats should be taken into account. Data
obtained in zebrafish will often need validation in more closely related animal models before
they can be extrapolated to humans. Therefore, the zebrafish model should not be considered
as a model organism replacing other animal models, but rather as an additional complementary
tool with specific advantages.
In conclusion, the initial characterization and expression analysis of all five steroid receptor
types, the generation of mutants and reporter lines and the identification of biomarkers to study
their action has made the zebrafish an ideal model system for research on steroid receptors. It is
therefore anticipated that in the next decade the role of the zebrafish in steroid receptor research
will significantly increase, particularly in research on EDCs and selective steroid receptor mod-
ulators.
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